Medication history
What was prescribed, at which dose and for how long.
Worth, per medication
$2.33
$2.33 to $13
How it is pricedGiven by uploading a document; the AI reads it into your file.
Patients usually have it with
Hepatitis CSjögren's syndromeChronic painAutismMigraineSchizophreniaAcid reflux (GERD)OCDPTSDCrohn's diseaseUlcerative colitisAtrial fibrillationMultiple sclerosisMenopauseThyroid cancerCoronary heart diseaseGlaucomaMacular degenerationOsteoporosisAcneADHDAnxietyEczemaBipolar disorderDepressionObesityPsoriasisHIV
Evidence about it (32)
- Direct-acting antiviral course (glecaprevir/pibrentasvir or sofosbuvir/velpatasvir)Records patients typically hold8 weeks of glecaprevir/pibrentasvir or 12 weeks of sofosbuvir/velpatasvir
- Hydroxychloroquine prescriptionRecords patients typically hold6–12 months
- Prescription drug monitoring program (PDMP) review of controlled-substance prescriptionsRecords patients typically holdevery 3 months or more frequently
- Antipsychotic prescription for behaviour that challenges, with an early reviewRecords patients typically holdafter 3–4 weeks
- Review of migraine preventive medication after it is startedRecords patients typically hold3 to 6 months after starting prophylactic treatment
- Clozapine prescription for treatment-resistant schizophreniaRecords patients typically holdat least 2 different antipsychotic drugs
- Annual review of long-term reflux and dyspepsia medicationRecords patients typically holdan annual review
- Full-dose proton pump inhibitor (PPI) courseRecords patients typically holdfor 4 or 8 weeks
- SSRI prescription, reviewed after 12 months of remissionRecords patients typically hold12 months after remission
- Venlafaxine or SSRI (such as sertraline) prescription for adults with PTSDRecords patients typically holdReview this treatment regularly
- Review of infliximab or adalimumab treatmentRecords patients typically holdat least every 12 months
- Review of biologic or JAK inhibitor treatmentRecords patients typically holdat least every 12 months
- Antidepressant prescription for chronic primary painRecords patients typically holdfor people aged 18 years and over
- Anticoagulation reviewRecords patients typically holdat least annually
- Review of spasticity medicinesRecords patients typically holdat least annually once the optimal dose has been reached
- Review of each menopause treatment (HRT and other treatments)Records patients typically holdat 3 months ... annually thereafter
- Thyroid hormone (levothyroxine) prescription at TSH-suppressing doseRecords patients typically holduntil follow-up review at 9 to 12 months
- Annual medication review (lipid-lowering treatment)Records patients typically holdannually
- Prostaglandin analogue eye drop prescriptionRecords patients typically holdgeneric PGA
- Intravitreal anti-VEGF injection treatmentRecords patients typically holdintravitreal anti-vascular endothelial growth factor (VEGF) treatment
- Oral bisphosphonate prescription (alendronate, ibandronate, risedronate)Records patients typically holdat least 5 years
- Maintenance treatment reviewRecords patients typically holdafter 12 weeks
- ADHD medication review (prescription history)Records patients typically holdat least once a year
- Anxiety drug treatment review (prescription history), generalised anxiety disorderRecords patients typically holdevery 3 months thereafter
- Anxiety drug treatment review (prescription history), panic disorderRecords patients typically hold8- to 12-week intervals
- Repeat prescription review (prescription history)Records patients typically holdat least once a year
- Annual review of treatment and care including medicationRecords patients typically holdat least annually
- Antidepressant medication review (prescription history)Records patients typically holdat least every 6 months
- Weight-management medicine response check (prescription history)Records patients typically holdless than 5% of the initial weight has been lost after 6 months
- Regular review of weight-management medicinesRecords patients typically holdregular review
- Review of potent topical corticosteroid use (prescription history)Records patients typically holdat least annually
- Dolutegravir-based first-line antiretroviral therapy prescriptionRecords patients typically holdpreferred first-line regimen